focus -WSS

focus

author：knowledge 2025-09-29 16:33:32 - browse：6

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Study links childhood stress with decline in older age

WSS

The a glaring gap in research on serious mental illness and primary care

Group behind ProMed defends move to subscription

'Null' research findings aren't empty of meaning. Let's publish them

Congress might make insulin pumps more accessible to the blind

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Resistance to opioid

hotspot

focus

hotspot

Drug repurposing or repositioning? The language matters

Long Covid research funding gets a major boost from NIH

Tori Bowie and the unacceptable rates of Black maternal death

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Virginia high school admissions case could be legal follow

Study links childhood stress with decline in older age

In age of alternative facts, a scholarly course on calling out crap

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Guidelines to prevent youth baseball injuries need more muscle

Biotech startup Celsius cuts 75% of staff ahead of first trial start

entertainment

'Null' research findings aren't empty of meaning. Let's publish them

Congress might make insulin pumps more accessible to the blind

Here’s what’s in the FDA plan to include pregnant women in clinical trials

H.R. 3 is the wrong path to lower drug costs

Florida officials tell state schools to teach AP Psychology 'in its entirety'

The cancer stories no one wants to hear

knowledge

entertainment

knowledge

entertainment